Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hamsten

Showing results (1-10 of 244) with videos related to

Pageof 25
Sort By:
Postgraduate Medical Journal|January 1, 1993
Lipids as a coronary risk factor: analysis of hyperlipidaemiasA Hamsten
Acta Medica Scandinavica|January 1, 1988
Apolipoproteins, dyslipoproteinaemia and premature coronary heart diseaseA Hamsten
Thrombosis Research|April 1, 1993
The hemostatic system and coronary heart diseaseA Hamsten
The New England Journal of Medicine|March 9, 1995
Hemostatic function and coronary artery diseaseA Hamsten
Lancet (London, England)|November 1, 1996
Molecular genetics as the route to understanding, prevention, and treatmentA Hamsten
Bailliere'S Clinical Endocrinology and Metabolism|December 1, 1990
Hypertriglyceridaemia, triglyceride-rich lipoproteins and coronary heart diseaseA Hamsten
Journal of Internal Medicine|April 16, 2008
Identifying the susceptibility genes for coronary artery disease: from hyperbole through doubt to cautious optimismA Hamsten, P Eriksson
Bailliere'S Clinical Haematology|June 1, 1995
Fibrinolysis and atherosclerosisA Hamsten, P Eriksson
Lakartidningen|January 9, 1991
[New methods accelerate the development of thrombolytic agents]B Wiman, A Hamsten
Seminars in Thrombosis and Hemostasis|July 1, 1990
The fibrinolytic enzyme system and its role in the etiology of thromboembolic diseaseB Wiman, A Hamsten
Pageof 25

Showing results (1-10 of 244) with videos related to

Sort By:
Pageof 25
Postgraduate Medical Journal|January 1, 1993
Lipids as a coronary risk factor: analysis of hyperlipidaemiasA Hamsten
Acta Medica Scandinavica|January 1, 1988
Apolipoproteins, dyslipoproteinaemia and premature coronary heart diseaseA Hamsten
Thrombosis Research|April 1, 1993
The hemostatic system and coronary heart diseaseA Hamsten
The New England Journal of Medicine|March 9, 1995
Hemostatic function and coronary artery diseaseA Hamsten
Lancet (London, England)|November 1, 1996
Molecular genetics as the route to understanding, prevention, and treatmentA Hamsten
Bailliere'S Clinical Endocrinology and Metabolism|December 1, 1990
Hypertriglyceridaemia, triglyceride-rich lipoproteins and coronary heart diseaseA Hamsten
Journal of Internal Medicine|April 16, 2008
Identifying the susceptibility genes for coronary artery disease: from hyperbole through doubt to cautious optimismA Hamsten, P Eriksson
Bailliere'S Clinical Haematology|June 1, 1995
Fibrinolysis and atherosclerosisA Hamsten, P Eriksson
Lakartidningen|January 9, 1991
[New methods accelerate the development of thrombolytic agents]B Wiman, A Hamsten
Seminars in Thrombosis and Hemostasis|July 1, 1990
The fibrinolytic enzyme system and its role in the etiology of thromboembolic diseaseB Wiman, A Hamsten
Pageof 25